Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Nucl Med Biol. 2021 Apr 21;98-99:8–17. doi: 10.1016/j.nucmedbio.2021.04.001

Table 1.

Pharmacokinetics of [64Cu]Cu-NOTA-aCD40.

Parameters
t1/2α (h) 0.6 ± 0.05
t1/2β (h) 65.9 ± 64.6
V1 (mL) 2 ± 0
Vss (mL) 1232 ± 605
CLtotal (mL/h) 0.3 ± 0.1
AUCtotal (%ID/mL × h) 347 ± 190

Data were fitted using a two-compartment model with i.v. bolus input.

t1/2,α = alpha phase half-life, t1/2,β = beta phase half-life, V1 = volume of distribution (central compartment), Vss = volume of distribution at steady-state, CLtotal = clearance, and AUCtotal = area under the curve.